Delivery Order SPE2DB22D2206-SPE2DB25FGS44
Award Date 4/24/25
Potential Completion Date 5/15/25
Potential Value $5.5K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $5,526.76 to AmerisourceBergen Drug Corp for 84 tablets of Xermelo 250 mg on July 23, 2025, with completion expected by August 13, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitively awarded procurement fulfilling pharmaceutical supply requirements for military healthcare systems. The work will be performed at AmerisourceBergen's corporate headquarters in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $5,526.76 to AmerisourceBergen Drug Corp for 84 tablets of Xermelo 250 mg on August 25, 2025, with an ultimate completion date of September 16, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Xermelo 250 mg tablets (84-count). This firm fixed-price delivery order, valued at $5,526.76, represents a non-set-aside competitive award with an ultimate completion date of September 24, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a $11,053.54 firm fixed price delivery order to AmerisourceBergen Drug Corp for Xermelo 250 mg tablets (84-count) on September 11, 2025, with an ultimate completion date of October 2, 2025. This non-competitive delivery order represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026. The place of performance is...
- The Defense Logistics Agency awarded a $5,526.76 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Xermelo 250 mg tablets (84-count units). This non-set-aside competitive award is scheduled for completion by August 11, 2025, with performance to be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency on September 11, 2025, for the supply of Xermelo 250 mg tablets (84-count units) under a firm fixed-price contract with a ceiling value of $11,053.54. The order is expected to be completed by October 2, 2025, and will be fulfilled from the vendor's corporate office in Conshohocken, Pennsylvania. This is a competitive award with no set-aside designation, reflecting AmerisourceBergen's capability to compete...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Xermelo 250 mg tablets (84-count) on September 9, 2025, with a ceiling value of $11,053.54 and an ultimate completion date of September 30, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen Drug...
- This delivery order, awarded August 18, 2025, to AmerisourceBergen Drug Corp provides 84 tablets of Xermelo 250 mg with a ceiling value of $5,526.76. The contract is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) without a set-aside designation, indicating open competitive procurement. The pharmaceutical product will be delivered to a location in Conshohocken, Pennsylvania, with an ultimate completion date of September 9, 2025. This award is issued under...
- This federal contract award, valued at $5,526.76, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the medication XERMELO 250 MG TABLET 84S, with a performance period extending to May 14, 2025. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999.00, which...
- The federal contract award is a delivery order with a firm fixed price of $5,526.76 awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of XERMELO 250 MG TABLET 84S to the Defense Logistics Agency, a defense agency. The award has an ultimate completion date of July 28, 2025 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant...